Alta Advisers’s AbbVie ABBV Stock Holding History

Alta Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Hold	6,765	–	–	0.53%	26
2025 Q4	$1.55M	Sell	6,765 -2,000	-23%	-$456K	0.56%	23
2025 Q3	$2.03M	Hold	8,765	–	–	0.62%	27
2025 Q2	$1.63M	Hold	8,765	–	–	0.58%	27
2025 Q1	$1.84M	Buy	8,765 +2,900	+49%	+$564K	0.78%	26
2024 Q4	$1.04M	Buy	5,865 +1,069	+22%	+$197K	0.66%	27
2024 Q3	$947K	Buy	4,796 +96	+2%	+$17.9K	0.43%	25
2024 Q2	$806K	Hold	4,700	–	–	0.39%	26
2024 Q1	$856K	Hold	4,700	–	–	0.42%	25
2023 Q4	$728K	Hold	4,700	–	–	0.39%	25
2023 Q3	$701K	Hold	4,700	–	–	0.41%	24
2023 Q2	$633K	Hold	4,700	–	–	0.36%	27
2023 Q1	$749K	Hold	4,700	–	–	0.45%	22
2022 Q4	$760K	Hold	4,700	–	–	0.46%	23
2022 Q3	$631K	Buy	+4,700	New	+$674K	0.4%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alta Advisers's ABBV Position: Q1 2026 in Review

Alta Advisers held its AbbVie (ABBV) position steady in Q1 2026 at 6,765 shares worth $1.47M. The position accounts for 0.53% of the portfolio, ranked #26.

Alta Advisers first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.03M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Alta Advisers held 6,765 shares of AbbVie worth $1.47M as of Q1 2026.
Alta Advisers left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.53% of Alta Advisers's portfolio in Q1 2026, its #26 holding.
Alta Advisers first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
Alta Advisers's AbbVie position peaked at $2.03M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.